Governed by the European Union Medical Device and IVD Regulations (EU 2017/745, 2017/746)
| Regulatory Authority | Federal Agency for Medicines, and Health Products (FAMHP) |
|---|---|
| Regulatory Authority Website Link | Click Here |
| Device Classification | I, IIa, IIb and III |
| Medical Device Regulations | EUMDR-2017/745 | Click Here |
| IVD Classification | A,B,C,D |
| In Vitro Diagnostics Regulations | (EU) 2017/746 | Click Here |
| Registration Process | Registration of distribution and import activities | Click Here |
| Registration Timeline | For Class I, it is 1 to 2 months and for other classes, it depends on the notified body and type of product |
| Technical Documentation Format |
The technical documentation should include at least:
|
| Requirement of Authorized Representative | Yes |
| Language Requirement | Labels must be in French and Dutch and German Language |
| Clinical Trials Information |
Guideline Submission Processes of Clinical Investigations according to MDR in Belgium | Click Here |
| Database | EUDAMED | Click Here |
| Declaration of Conformity |
An EU declaration of conformity (DoC) is a mandatory document that you as a manufacturer or your authorised representative need to sign to declare that your products comply with the EU requirements. By signing the DoC you take full responsibility for your product's compliance with the applicable EU law. | Click Here |
| Certificate of Free Sale |
Free Sales Certificates (FSC) | Click Here |
| Reportable Incidents |
- Any dysfunction or any change of the characteristics and/or performance of a device, and any inadequacy in the labelling or instructions, which might lead to or have led to death or serious relapse in the state of health of a patient, a user or a third party. - Any technical or medical reason related to the characteristics or performance of a device for reasons shown in the previous paragraph and having led to the systematic withdrawal from the market by a manufacturer of devices of the same type. | Click Here |
| Adverse Event Reporting Timelines | For all reportable events which indicate an imminent risk of death, serious injury, or serious illness and that require prompt remedial action for other patients/subjects, users or other persons, or a new finding to it: Immediately, but |
| Field Safety Corrective Action |
The FSN provides information on the identification of the affected devices and the reasons for the field safety corrective action. The FSN describes the risks to patients, users or others affected by the problem. It also provides the measures to be taken by users to reduce or eliminate the risk. | Click Here |
| Additional Information | For low-risk classes, no prior notified body approval is needed, except for sterile devices and reusable surgical instruments. Custom-made devices, systems, and procedure packs do not need CE marking, but must be approved by a notified body if they are not compatible or if the manufacturer wants to extend the use of their device to other indications. |
| Contact Phone | + 32 2 528 40 00 |
| Contact Email | info.meddev@fagg-afmps.be |
| Contact Address | Federal Agency for Medicines and Health Products Avenue Galilée 5/03 1210 BRUSSELS |